标题
Aspartate β-hydroxylase as a target for cancer therapy
作者
关键词
-
出版物
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 39, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-08-18
DOI
10.1186/s13046-020-01669-w
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Prometastatic Secretome Trafficking via Exosomes Initiates Pancreatic Cancer Pulmonary Metastasis
- (2020) Kosuke Ogawa et al. CANCER LETTERS
- Kinetic parameters of human aspartate/asparagine-β-hydroxylase suggest that it has a possible function in oxygen sensing
- (2020) Lennart Brewitz et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Synthesis of Novel Pyridine‐Carboxylates as Small‐Molecule Inhibitors of Human Aspartate/Asparagine‐β‐Hydroxylase
- (2020) Lennart Brewitz et al. ChemMedChem
- Targeting Aspartate Beta-Hydroxylase with the Small Molecule Inhibitor MO-I-1182 Suppresses Cholangiocarcinoma Metastasis
- (2020) Katsuya Nagaoka et al. DIGESTIVE DISEASES AND SCIENCES
- The interplay between innate and adaptive immunity in cancer shapes the productivity of cancer immunosurveillance
- (2020) Renee B. Chang et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Aspartate-β-Hydroxylase: A Promising Target to Limit the Local Invasiveness of Colorectal Cancer
- (2020) Roberto Benelli et al. Cancers
- Aspartate β-hydroxylase targeting in castration-resistant prostate cancer modulates the NOTCH/HIF1α/GSK3β crosstalk
- (2020) Paola Barboro et al. CARCINOGENESIS
- Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma
- (2019) Katsuya Nagaoka et al. CANCER LETTERS
- Dual prognostic role of 2-oxoglutarate-dependent oxygenases in ten cancer types: implications for cell cycle regulation and cell adhesion maintenance
- (2019) Wai Hoong Chang et al. Cancer Communications
- Cepharanthine: An update of its mode of action, pharmacological properties and medical applications
- (2019) Christian Bailly PHYTOMEDICINE
- Systematic Profiling of Alternative mRNA Splicing Signature for Predicting Glioblastoma Prognosis
- (2019) Xueran Chen et al. Frontiers in Oncology
- ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis
- (2019) Qiushi Lin et al. Molecular Cancer
- Aspartate/asparagine-β-hydroxylase crystal structures reveal an unexpected epidermal growth factor-like domain substrate disulfide pattern
- (2019) Inga Pfeffer et al. Nature Communications
- The role of bosutinib in the treatment of chronic myeloid leukemia
- (2019) Carlo Gambacorti-Passerini et al. Future Oncology
- Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway
- (2019) Kosuke Ogawa et al. Journal of Hematology & Oncology
- Aspartate beta-hydroxylase promotes cholangiocarcinoma progression by modulating RB1 phosphorylation
- (2018) Chiung-Kuei Huang et al. CANCER LETTERS
- Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape
- (2018) Max D. Wellenstein et al. IMMUNITY
- Notch Signaling as a Regulator of the Tumor Immune Response: To Target or Not To Target?
- (2018) Mahnaz Janghorban et al. Frontiers in Immunology
- Hydroxylase Activity of ASPH Promotes Hepatocellular Carcinoma Metastasis Through Epithelial-to-Mesenchymal Transition Pathway
- (2018) Qifei Zou et al. EBioMedicine
- Recent advances in research on aspartate β-hydroxylase (ASPH) in pancreatic cancer: A brief update
- (2018) Guofang Hou et al. Bosnian Journal of Basic Medical Sciences
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Phase 1 open-label trial to evaluate the safety and immunogenicity of PAN-301-1, a novel nanoparticle therapeutic vaccine, in patients with biochemically relapsed prostate cancer.
- (2018) Luke T. Nordquist et al. JOURNAL OF CLINICAL ONCOLOGY
- NOTCH Signaling in T-Cell-Mediated Anti-Tumor Immunity and T-Cell-Based Immunotherapies
- (2018) Michelle A. Kelliher et al. Frontiers in Immunology
- Natural and synthetic bioactive inhibitors of glycogen synthase kinase
- (2017) Imran Khan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Development of a novel anti-human aspartyl-(asparaginyl) β-hydroxylase monoclonal antibody with diagnostic and therapeutic potential
- (2017) Ting Huyan et al. Oncology Letters
- Genetic Mutations and Epigenetic Modifications: Driving Cancer and Informing Precision Medicine
- (2017) Krysta Mila Coyle et al. Biomed Research International
- Aspartate β-hydroxylase disrupts mitochondrial DNA stability and function in hepatocellular carcinoma
- (2017) C Tang et al. Oncogenesis
- Activation of signal transduction pathways during hepatic oncogenesis
- (2016) Waihong Chung et al. CANCER LETTERS
- Forced Activation of Notch in Macrophages Represses Tumor Growth by Upregulating miR-125a and Disabling Tumor-Associated Macrophages
- (2016) Jun-Long Zhao et al. CANCER RESEARCH
- Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma
- (2016) Yoshifumi Iwagami et al. HEPATOLOGY
- Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression
- (2016) Chiung-Kuei Huang et al. PLoS One
- Notch in T Cell Differentiation: All Things Considered
- (2015) Derk Amsen et al. TRENDS IN IMMUNOLOGY
- Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma
- (2015) Yoshito Tomimaru et al. VACCINE
- The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy
- (2015) Brock Humphries et al. Oncotarget
- Potential Role of Phosphorylation as a Regulator of Aspartyl-(asparaginyl)-β-hydroxylase: Relevance to Infiltrative Spread of Human Hepatocellular Carcinoma
- (2015) Diana L. Borgas et al. Liver Cancer
- Aspartate β-hydroxylase expression promotes a malignant pancreatic cellular phenotype
- (2015) Xiaoqun Dong et al. Oncotarget
- Synthesis of a FTO Inhibitor with Anticonvulsant Activity
- (2014) Guanqun Zheng et al. ACS Chemical Neuroscience
- Cancer Immunotherapy and Breaking Immune Tolerance: New Approaches to an Old Challenge
- (2014) A. Makkouk et al. CANCER RESEARCH
- A cell-surface β-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma
- (2014) Arihiro Aihara et al. HEPATOLOGY
- Inhibition of human natural killer cell functional activity by human aspartyl β-hydroxylase
- (2014) Ting Huyan et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Non-Canonical Notch Signaling in Cancer and Immunity
- (2014) Furkan Ayaz et al. Frontiers in Oncology
- Upregulation of T-cell factor-4 isoform-responsive target genes in hepatocellular carcinoma
- (2013) Yoshito Tomimaru et al. LIVER INTERNATIONAL
- Invading one step at a time: the role of invadopodia in tumor metastasis
- (2013) H Paz et al. ONCOGENE
- Tumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinoma
- (2012) Masafumi Shimoda et al. JOURNAL OF HEPATOLOGY
- Immunization with aspartate-β-hydroxylase-loaded dendritic cells produces antitumor effects in a rat model of intrahepatic cholangiocarcinoma
- (2011) Takehiro Noda et al. HEPATOLOGY
- Single-Chain Variable Fragment Antibody Against Human Aspartyl/Asparaginyl beta-Hydroxylase Expressed in Recombinant Escherichia coli
- (2011) Hui Yang et al. HYBRIDOMA
- Notch signaling and Notch signaling modifiers
- (2011) Michael M. Wang INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Aspartyl-(asparaginyl) β-Hydroxylase, Hypoxia-Inducible Factor-1α and Notch Cross-Talk in Regulating Neuronal Motility
- (2011) Margot Lawton et al. Oxidative Medicine and Cellular Longevity
- siRNA inhibition of aspartyl-asparaginyl β-hydroxylase expression impairs cell motility, Notch signaling, and fetal growth
- (2011) Fusun Gundogan et al. PATHOLOGY RESEARCH AND PRACTICE
- Notch Signaling Determines the M1 versus M2 Polarization of Macrophages in Antitumor Immune Responses
- (2010) Yao-Chun Wang et al. CANCER RESEARCH
- Overexpression of aspartyl-(asparaginyl)-β-hydroxylase in hepatocellular carcinoma is associated with worse surgical outcome
- (2010) Kui Wang et al. HEPATOLOGY
- The distribution and expression profiles of human Aspartyl/Asparaginyl beta-hydroxylase in tumor cell lines and human tissues
- (2010) Xue ONCOLOGY REPORTS
- Identification of Novel Gene Amplifications in Breast Cancer and Coexistence of Gene Amplification with an Activating Mutation of PIK3CA
- (2009) M. Kadota et al. CANCER RESEARCH
- Prognostic value of aspartyl (asparaginyl)-β-hydroxylase/humbug expression in non–small cell lung carcinoma
- (2009) Martin Luu et al. HUMAN PATHOLOGY
- Monoclonal Antibodies Against Human Aspartyl (Asparaginyl) beta-Hydroxylase Developed by DNA Immunization
- (2009) Tao Xue et al. HYBRIDOMA
- IRS1Regulation by Wnt/β-Catenin Signaling and Varied Contribution ofIRS1to the Neoplastic Phenotype
- (2009) Guido T. Bommer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ethanol impaired neuronal migration is associated with reduced aspartyl-asparaginyl-β-hydroxylase expression
- (2008) Jade J. Carter et al. ACTA NEUROPATHOLOGICA
- Notch signaling is activated by TLR stimulation and regulates macrophage functions
- (2007) Tanapat Palaga et al. EUROPEAN JOURNAL OF IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started